An Open Label, Phase II Trial of Afatinib with Paclitaxel for the Neoadjuvant Treatment of Triple-Negative Breast Cancer and Research of Biomarkers of Activity and Efficacy of Afatinib (II)

2015-08-012024-05-13https://scholars.lib.ntu.edu.tw/handle/123456789/644982An Open Label, Phase II Trial of Afatinib with Paclitaxel for the Neoadjuvant Treatment of Triple-Negative Breast Cancer and Research of Biomarkers of Activity and Efficacy of Afatinib (II)